HOME JOIN TOOLS SITEMAP CONTACT
April 26, 2015, 7:11 pm
Home
With 'steroids' gone, fewer stock market records to celebrate
April 26th, 2015
Read full story for latest details.

Casino drama: Elaine Wynn ousted
April 26th, 2015
Talk about crapping out. Elaine Wynn has been kicked off the board of the casino empire she helped build.

How a big Italian bank was slammed by a hoax
April 26th, 2015
Read full story for latest details.

10 things you must know about Apple before earnings
April 26th, 2015
Read full story for latest details.

Sorry, Starbucks haters! #RaceTogether hasn't hurt it
April 26th, 2015
Starbucks reported huge growth in sales and profits. The stock is at a record high. So much for that social media backlash against CEO Howard Schultz.

Problem: Many investors are 'rate hike newbies'
April 26th, 2015
The Federal Reserve is preparing to raise interest rates. That kind of liftoff hasn't happened since 2004.

Stocks: 6 things to know before the open
April 26th, 2015
Read full story for latest details.

Emerging market stocks are surging. Is it triumph or trickery?
April 26th, 2015
The MSCI Emerging Markets Index is up over 10% this year. That's way better than U.S. markets.


Get Daily Stock Picks



Featured Stories

lick here to visit Yahoo Finance
Deutsche Bank first-quarter profit falls by half as legal charges bite
Sick Investment Tools, Copyright © 2009-2011, Sick Investment Tools LLC. All rights reserved. The content of this site may not be redistributed without the express written consent of Sick Investment Tools. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Sick Investment Tools as well as a link to www.sickinvestmenttools.com. Your privacy is important to usówe will never rent or sell your e-mail or personal information. Please read our Privacy Policy.

No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Sick Investment Tools does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors and consultants of Sick Investment Tools may actively trade in the investments discussed in this publication. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.